コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al approach (lesion excision with margins or lobectomy).
2 ates ranged from 10% (prostatectomy) to 56% (lobectomy).
3 rate and should be considered for diagnostic lobectomy.
4 donors underwent MRC, and subsequently right lobectomy.
5 survival for PTC > or =1.0 cm compared with lobectomy.
6 f 97 patients underwent diagnostic biopsy at lobectomy.
7 NSCLC were prospectively registered for VATS lobectomy.
8 al thyroidectomy, and 8946 (17.1%) underwent lobectomy.
9 long-term seizure outcome following frontal lobectomy.
10 n = 37) and after (n = 24) anterior temporal lobectomy.
11 had comorbid medical problems that precluded lobectomy.
12 raft surgery with cardiopulmonary bypass and lobectomy.
13 PVE subsequently underwent extended hepatic lobectomy.
14 tients treated with limited resection versus lobectomy.
15 intraoperative frozen section during thyroid lobectomy.
16 ts required an hepatic lobectomy or extended lobectomy.
17 olization therapy, and one patient underwent lobectomy.
18 d dysphasia for 6 months after left temporal lobectomy.
19 e free for 1 year or more following temporal lobectomy.
20 1.19; upper 95% CI, 1.36) were equivalent to lobectomy.
21 iated with total thyroidectomy compared with lobectomy.
22 4,926 underwent total thyroidectomy and 6849 lobectomy.
23 vival advantage for total thyroidectomy over lobectomy.
24 [95% CI, 1.29-1.75]; P < .001) compared with lobectomy.
25 larify the use of ECoG in tailoring temporal lobectomy.
26 val rates that approximate those achieved by lobectomy.
27 of retinal ganglion cells follows occipital lobectomy.
28 btained by either fiberoptic bronchoscopy or lobectomy.
29 age I NSCLC patients ineligible for anatomic lobectomy.
30 ot significantly different from those having lobectomy.
31 23), adenomata (47), and 20 live donor right lobectomies.
32 these 111 patients underwent successful VATS lobectomies.
33 12,228 prostatectomies, and 10,151 pulmonary lobectomies.
35 rs, and treatment distribution was 79.3% for lobectomy, 16.5% for sublobar resection, and 4.2% for SA
36 3 years, unadjusted mortality was lowest for lobectomy (25.0%), followed by sublobar resection (35.3%
37 Unadjusted 90-day mortality was highest for lobectomy (4.0%) followed by sublobar resection (3.7%; P
40 the discarded terms "right and left hepatic lobectomy" after the Nomenclature was introduced in 2000
42 acoscopic pulmonary resections, including 35 lobectomies and 15 segmentectomies, and 183 patients und
44 ergoing pre-surgical evaluation for temporal lobectomy and 30 normal subjects performed a complex vis
47 e of the study was to compare survival after lobectomy and limited resection among Medicare patients
48 aluation in less than 24 hr, and donor right lobectomy and living donor transplantation were performe
50 n between activation ipsilateral to temporal lobectomy and memory outcome was observed, with no signi
52 Reports of single-incision thoracoscopic lobectomy and segmentectomy for lung cancer are limited,
55 ections included 237 trisegmentectomies, 394 lobectomies, and 370 resections encompassing less than a
56 horacic cavity (mediastinal mass resections, lobectomies, and esophagectomies); unfortunately there a
58 gent chemotherapy, resection with at least a lobectomy, and PORT (hazard ratio, 0.886; 95% CI, 0.798
60 herapy with or without resection (preferably lobectomy) are options for patients with stage IIIA(N2)
62 es should explore the potential for temporal lobectomy based on interictal electroencephalography and
64 reviewed 70 patients who underwent a frontal lobectomy between 1995 and 2003 (mean follow-up 4.1 +/-
65 ecutive patients who underwent thoracoscopic lobectomy between June 1999 and January 2006 was queried
66 ation and oxidative stress in patients after lobectomy, but not after the milder insult associated wi
67 , OS was improved for patients who underwent lobectomy, but not pneumonectomy, versus chemotherapy pl
68 l cell lung cancer (NSCLC), as compared with lobectomy by conventional thoracotomy, include less post
69 se was queried for patients having undergone lobectomy by either thoracotomy or VATS between 2000 and
70 2.31; 95% CI, 10 063.66-15 420.94; P < .001; lobectomy: coefficient, 6336.42; 95% CI, 3934.61-8737.24
71 s used to identify matched segmentectomy and lobectomy cohorts (n = 312 patients per group) using a p
72 e-matching analysis of well-matched SABR and lobectomy cohorts demonstrated similar overall survival
74 d bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resect
76 t coronary artery bypass grafting, pulmonary lobectomy, endovascular abdominal aortic aneurysm repair
77 g coronary artery bypass grafting, pulmonary lobectomy, endovascular abdominal aortic aneurysm repair
78 r coronary-artery bypass grafting, pulmonary lobectomy, endovascular repair of abdominal aortic aneur
79 ncluded 13 right trisegmentectomies, 6 right lobectomies extended to include the caudate lobe, and 3
80 metastatic NSCLC who had received at least a lobectomy followed by multiagent chemotherapy and radiot
86 to be a universal event after right hepatic lobectomy for live-donor adult liver transplantation acc
87 Database was queried for patients undergoing lobectomy for lung cancer from 2004 to 2013 at Commissio
94 years of age undergoing limited resection or lobectomy for stage IA tumors < or =2 cm appears to be s
95 geons who recommend total thyroidectomy over lobectomy for subcentimeter unifocal thyroid cancer were
96 lective amygdalohippocampectomy and temporal lobectomy for temporal lobe epilepsy were associated wit
97 tients who had undergone unilateral temporal lobectomy for the treatment of epilepsy (12 left, 11 rig
98 ative) in 95 patients who underwent temporal lobectomy for treatment of nonneoplastic epilepsy were e
99 tients undergoing total thyroidectomy versus lobectomy for tumors 1.0-4.0 cm [hazard ratio (HR) = 0.9
103 ivalent survival rates to those treated with lobectomy (HR, 0.97; upper 95% CI, 1.07), outcomes of th
104 Cases of amnesia after unilateral temporal lobectomy illustrate the complexity of intra- and inter-
106 nonlesional patients who underwent temporal lobectomies in our epilepsy center from 1995 to 1998.
108 that limited resection is not equivalent to lobectomy in older patients with invasive non-small-cell
109 that limited resection was not equivalent to lobectomy in patients with adenocarcinoma (HR, 1.21; upp
110 ical data relate to prognosis after temporal lobectomy in patients with independent bilateral tempora
112 associated with better overall survival than lobectomy in the first 6 months after diagnosis (AHR, 0.
113 imited resection (wedge or segmentectomy) or lobectomy in the Surveillance, Epidemiology, and End Res
117 video-assisted thoracoscopic surgery (VATS) lobectomy is beneficial in high-risk pulmonary patients.
121 tive histologic margins, concomitant hepatic lobectomy, lack of nodal disease, well-differentiated hi
123 topographical memory, and the left temporal lobectomy (LTL) patients worse on tests of context-depen
124 patients underwent mediastinoscopy (n = 3), lobectomy (n = 2), thoracoscopic wedge resection (n = 2)
126 p of 5.4 years, comparing segmentectomy with lobectomy, no differences were noted in locoregional (5.
127 rthermore, when comparing segmentectomy with lobectomy, no significant differences were noted in 5-ye
129 (NSCLC) using a standard definition for VATS lobectomy (one 4- to 8-cm access and two 0.5-cm port inc
130 18 years of age scheduled for elective open lobectomy or bilobectomy for malignancy were eligible fo
131 18 years of age scheduled for elective open lobectomy or bilobectomy for malignancy were eligible fo
133 ung cancer < or =2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge r
134 r-specific survival of patients treated with lobectomy or limited resection was compared after adjust
135 ession-free survival rate was the same after lobectomy or more extensive thyroid procedures, but comp
136 n, bilateral resection, extensive resection (lobectomy or more), gender, number of hepatic tumors, pr
138 collapse in patients who have had a previous lobectomy or pneumonectomy and require thoracic surgery.
140 ) analysis in the 180 patients who underwent lobectomy or pneumonectomy led to the elimination of sex
143 aging and resection of the tumor (usually by lobectomy or pneumonectomy), the patients were randomly
146 ts underwent multiple-incision thoracoscopic lobectomy or segmentectomy between January 2005 and Dece
147 incision and multiple-incision thoracoscopic lobectomy or segmentectomy for lung cancer has not been
148 nts with lung cancer underwent thoracoscopic lobectomy or segmentectomy via a single-incision or mult
150 ablation, 35% partial hepatectomy (ie, left lobectomy), or a sham operation (controls) by using Kapl
151 iting list to undergo, lung transplantation, lobectomy, or lung volume-reduction surgery, or had sele
152 titution series demonstrated benefit of VATS lobectomy over lobectomy via thoracotomy in poor pulmona
155 including 392 segmentectomy patients and 800 lobectomy patients was used to identify matched segmente
157 increase at a significantly greater rate in lobectomy patients with poor pulmonary function after th
159 tios were determined intraoperatively during lobectomies performed to alleviate drug-resistant seizur
162 frontal eyefield ablation, or after frontal lobectomy plus forebrain commissurotomy (n = 3 in each o
163 truction, carotid endarterectomy (CEA), lung lobectomy/pneumonectomy, open and laparoscopic cholecyst
164 rapy and lung cancer status after left upper lobectomy presented to our hospital for elective cardiov
168 leasant memories, whereas the right temporal lobectomy (RTL) group produced significantly fewer memor
169 y and test type such that the right temporal lobectomy (RTL) patients were worse on tests of topograp
170 ter the type or completeness of the surgery (lobectomy: S: 56%, CT-S: 60%, complete resection: S: 80%
171 ancer and who would require extended hepatic lobectomy should have hepatic resection delayed for at l
172 Histological results obtained from left lobectomy specimens showed hepatobiliary cystadenocarcin
174 underwent definitive treatment consisting of lobectomy, sublobar resection, or stereotactic ablative
175 studies involving patients who had temporal lobectomy surgeries have also revealed changes in emotio
176 essment of memory changes following temporal lobectomy surgery emphasize the complexity of subjective
179 the STS database, 12,970 patients underwent lobectomy (thoracotomy, n = 8439; VATS, n = 4531) and me
180 reated specifically for analysis of temporal lobectomy tissue and the Braak staging, which was limite
181 tial memory of 19 left and 19 right temporal lobectomy (TL) patients was compared with that of 16 nor
183 The donor operation consisted of a right lobectomy uniformly performed throughout the series as d
185 demonstrated benefit of VATS lobectomy over lobectomy via thoracotomy in poor pulmonary function pat
187 In this large propensity-matched comparison, lobectomy was associated with modestly increased freedom
188 ctomy was the appropriate extent of surgery, lobectomy was correctly performed more often with routin
190 nts who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and
192 In the 501 patients with non-sTC for whom lobectomy was the appropriate extent of surgery, lobecto
194 ytic neoplasm) cytology who received initial lobectomy were 2.5 times more likely to require 2-stage
195 ood (usually as part of an anterior temporal lobectomy) were not impaired in ToM reasoning relative t
196 treated with limited resection compared with lobectomy when data was analyzed stratifying and matchin
197 ltrations - fibrotic changes, giving rise to lobectomy, while in the last of these cases, the course
198 (TLE) undergoing standard anterior temporal lobectomy with amygdalohippocampectomy (ATL), but the ut
201 randomly assigned in a 1:1 ratio to SABR or lobectomy with mediastinal lymph node dissection or samp
202 age I, non-small-cell lung cancer (NSCLC) is lobectomy with mediastinal lymph node dissection or samp
206 and 17.8% (806/4531) in patients undergoing lobectomy with thoracotomy and VATS, respectively (P < 0
208 ingle individual underwent anterior temporal lobectomy, with subsequent seizure freedom and histopath
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。